Spasticity management with botulinum toxin: development and evaluation of a tool for audit
- PMID: 22674237
- DOI: 10.2340/16501977-0977
Spasticity management with botulinum toxin: development and evaluation of a tool for audit
Abstract
Objective: To develop and evaluate tools for the audit of spasticity management with botulinum toxin.
Design: Audit tools to assess the organisation of services and process of care were developed with a consensus process. The tools were piloted across 8 services using a retrospective case note audit. Inter-rater reliability was assessed, using percentage agreement and kappa scores. Clinicians involved in the pilot were surveyed and qualitative feedback was analysed.
Results: Eight services (100%) completed service Organisation tools and 7 (88%) returned process of Care tools. One hundred sets of clinical records were audited, with 34 used to assess inter-rater reliability. Eleven items on the process of care tool demonstrated a good degree of inter-rater agreement, but 6 require further development. In the qualitative analysis clinicians stated that the tools captured indicators of quality, and that they would use them again. They recommended that patient satisfaction was included as a measure of quality. The audit has been used practically in the pilot services to provide an impetus for quality improvement.
Conclusions: The majority of the audit questions showed a good level of reliability, and clinician feedback supports face validity but a larger scale evaluation is required.
Similar articles
-
Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).Neurology. 2009 Sep 1;73(9):736; author reply 737-8. doi: 10.1212/WNL.0b013e3181af0b6e. Neurology. 2009. PMID: 19720984 No abstract available.
-
Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).Neurology. 2009 Sep 1;73(9):736-7; author reply 737-8. Neurology. 2009. PMID: 19728407 No abstract available.
-
The effects of botulinum toxin in spasticity and headaches: a common key?Funct Neurol. 2008 Apr-Jun;23(2):61. Funct Neurol. 2008. PMID: 18671904 No abstract available.
-
Pharmacologic treatment of spasticity in children.Semin Pediatr Neurol. 2010 Dec;17(4):261-7. doi: 10.1016/j.spen.2010.10.009. Semin Pediatr Neurol. 2010. PMID: 21183133 Review.
-
[Treatment of spasticity with injections of botulinum toxin. Review of the literature].Neurochirurgie. 1998 Sep;44(3):192-6. Neurochirurgie. 1998. PMID: 9827435 Review. French.
Cited by
-
Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.Neural Regen Res. 2014 Aug 15;9(16):1525-31. doi: 10.4103/1673-5374.139479. Neural Regen Res. 2014. PMID: 25317170 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources